Publications by authors named "Joyce Varughese"

Claim this Profile
C
Case Series: Rare cystic variant of adenomatoid tumor of the uterus.
Prasanna D Tati, Muhammad Omar Afridi, Angelica Patel, Monika Mansmann, Victoria Petty, Joyce Varughese

Gynecol Oncol Rep· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic insights into fungal mitochondrial outer membrane protein biogenesis.
Kathryn A Diederichs, Ashley S Pitt, Joyce T Varughese, Taylor N Hackel, Susan K Buchanan

Curr Opin Struct Biol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Role of Voltage-Dependent Anion Channel in Mitochondrial Dysfunction and Human Disease.
Joyce T Varughese, Susan K Buchanan, Ashley S Pitt

Cells· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant recurrence of Female Adnexal Tumor of Probable Wolffian Origin (FATWO).
Amal Amir, Katherine Jane Chua, Joyce Varughese

Gynecol Oncol Rep· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fluorodeoxyglucose positron-emission tomography-magnetic resonance hybrid imaging: An emerging tool for staging of cancer of the uterine cervix.
Alina Nazir, Robert Matthews, Annapurneswara Rao Chimpiri, Melissa Henretta, Joyce Varughese

World J Nucl Med· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accuracy in Referrals to Gynecologic Oncologists Based on Clinical Presentation for Ovarian Mass.
Katherine Jane C Chua, Ricky D Patel, Radhika Trivedi, Patricia Greenberg, Kyle Beiter, Joyce Varughese

Diagnostics (Basel)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine torsion with necrosis of bilateral adnexa in a postmenopausal woman.
Katherine Jane Chua, Ricky Patel, Armina Eana, Joyce Varughese

BMJ Case Rep· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms of resistance to HER2-targeted therapies in HER2-amplified uterine serous carcinoma, and strategies to overcome it.
Gulden Menderes, Salvatore Lopez, Chanhee Han, Gary Altwerger, Stepan Gysler, Joyce Varughese

Discov Med· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel targeted therapies in ovarian and uterine carcinosarcomas.
Chanhee Han, Gary Altwerger, Gulden Menderes, Kaitlin Haines, Jacqueline Feinberg, Joyce Varughese

Discov Med· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Syndrome of Inappropriate Antidiuretic Hormone after vinorelbine treatment.
Mai Hoang, Joyce Varughese, Elena Ratner

J Oncol Pharm Pract· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma.
Siming Zhao, Murim Choi, John D Overton, Stefania Bellone, Dana M Roque, Joyce Varughese

Proc Natl Acad Sci U S A· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clear cell cancer of the uterine corpus: the association of clinicopathologic parameters and treatment on disease progression.
Joyce Varughese, Pei Hui, Lingeng Lu, Herbert Yu, Peter E Schwartz

J Oncol· August 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas.
Federica Guzzo, Stefania Bellone, Natalia Buza, Pei Hui, Luisa Carrara, Joyce Varughese

Int J Gynecol Pathol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A survey of gynecologic oncologists regarding the end-of-life discussion: a pilot study.
Karim S El-Sahwi, Jessica Illuzzi, Joyce Varughese, Nina Carusillo, Elena S Ratner

Gynecol Oncol· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Eradication of chemotherapy-resistant CD44+ human ovarian cancer stem cells in mice by intraperitoneal administration of Clostridium perfringens enterotoxin.
Francesca Casagrande, Emiliano Cocco, Stefania Bellone, Christine E Richter, Marta Bellone, Joyce Varughese

Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cervical carcinomas overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.
Joyce Varughese, Emiliano Cocco, Stefania Bellone, Elena Ratner, Dan-Arin Silasi

Am J Obstet Gynecol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trop-2 overexpression in poorly differentiated endometrial endometrioid carcinoma: implications for immunotherapy with hRS7, a humanized anti-trop-2 monoclonal antibody.
Eliana Bignotti, Antonella Ravaggi, Chiara Romani, Marcella Falchetti, Silvia Lonardi, Joyce Varughese

Int J Gynecol Cancer· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine and ovarian carcinosarcomas overexpressing Trop-2 are sensitive to hRS7, a humanized anti-Trop-2 antibody.
Rhoda Raji, Federica Guzzo, Luisa Carrara, Joyce Varughese, Emiliano Cocco

J Exp Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGF(c) chimeric protein targeting tissue factor.
Emiliano Cocco, Joyce Varughese, Natalia Buza, Stefania Bellone, Ken-Yu Lin

Clin Exp Metastasis· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of αV-integrins in uterine serous papillary carcinomas; implications for targeted therapy with intetumumab (CNTO 95), a fully human antagonist anti-αV-integrin antibody.
Marta Bellone, Emiliano Cocco, Joyce Varughese, Stefania Bellone, Paola Todeschini

Int J Gynecol Cancer· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine serous papillary carcinomas overexpress human trophoblast-cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized anti-Trop-2 monoclonal antibody.
Joyce Varughese, Emiliano Cocco, Stefania Bellone, Maria de Leon, Marta Bellone

Cancer· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cancer care inequity for women in resource-poor countries.
Joyce Varughese, Susan Richman

Rev Obstet Gynecol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-grade, chemotherapy-resistant primary ovarian carcinoma cell lines overexpress human trophoblast cell-surface marker (Trop-2) and are highly sensitive to immunotherapy with hRS7, a humanized monoclonal anti-Trop-2 antibody.
Joyce Varughese, Emiliano Cocco, Stefania Bellone, Marta Bellone, Paola Todeschini

Gynecol Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of tissue factor in adenocarcinoma and squamous cell carcinoma of the uterine cervix: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor.
Emiliano Cocco, Joyce Varughese, Natalia Buza, Stefania Bellone, Michelle Glasgow

BMC Cancer· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis